Nuevos inversores adquieren acciones de Airway Medix
Nuevos inversores adquirieron 11,6 millones de acciones de Airway Medix por unos 3,944 millones de PLN, alrededor de 900.000 EUR. Tras la operación, CoOpera posee el 12,41 % y Kröner Medizintechnik el 3,54 % de la empresa.
Texto completo en inglés (original)
Warsaw, November 20, 2023: Airway Medix is finalizing agreements regarding the acquisition of issue shares within the authorized capital in the amount of PLN 3.944 million (EUR 900,000) by new investors: CoOpera Finanzierungen Deutschland, Kröner Medizintechnik and a Swiss advisory and investment group. New investors will invest up to EUR 2 million and will be operationally involved in the commercialization of products on the EU and US markets.
As a result of the agreements, 11.6 million shares were acquired, and CoOpera Finanzierungen Deutschland and Kröner Medizintechnik will become owners of 12.41 percent and 3.54 percent of the increased share capital.
Airway Medix focuses on innovative medical devices supporting the process of mechanical ventilation of patients, holding international patents. Partners, thanks to their experience in the industry, will support product development and commercialization processes.
About Airway Medix S.A.: Airway Medix S.A. focuses on the research, development and commercialization of innovative single-use devices for mechanically ventilated patients in Intensive Care Units (ICUs), as well as life-threatening patients and anesthesiology departments. The products offered by Airway Medix address the most pressing clinical needs and fill a gap in current medical devices. Airway Medix S.A. has been listed on the Warsaw Stock Exchange since 2014.
Las notas de prensa se publican tal como las emitió Airway Medix S.A. Las afirmaciones sobre los productos siguen las instrucciones de uso.
